Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The purpose of clinical trials is to evaluate safety and tolerability of Fetal Mesencephalic
Dopamine Neuronal Precursor Cells as a treatment for Patients with Parkinson's disease.